MRES

 
Common Stock Dark or Defunct
OTC Pink No Information
Contact Info
  • Institute of BioMedical Research
  • Ljubljanska bb,
  • Podgorica 81000
  • Montenegro

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Mar 29, 2013
Audited Financials Unaudited
Latest Report Jun 30, 2015 Quarterly Report
CIK 0000894561
Fiscal Year End 3/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 8071 - Medical laboratories
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 1990
Employees 26 a/o May 07, 2014
Company Officers/Contacts
Drasko Pekovic President, CEO
Company Directors
Drasko Pekovic
Company Notes
  • Formerly=Neuro-Biotech Corp. until 4-2014
  • Formerly=M45 Mining Resources, Inc. until 6-2010
  • Formerly=Quantitative Methods Corp. until 4-07
Service Providers
Accounting/Auditing Firm
KBL, LLP
114 West 47th Street, 19th Floor
Suite 1900
New York, NY, 10036
United States

Legal Counsel
Stephen A. Zrenda Jr. Esq.
12313 Hidden Forest Blvd
Oklahoma City, OK, 73142
United States

Investor Relations Firm
Not Available
MRES Security Details
Share Structure
Market Value1 $253,884 a/o Dec 06, 2016
Authorized Shares 2,000,000,000 a/o Dec 31, 2014
Outstanding Shares 846,280,777 a/o Dec 31, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 344,995,907 a/o Sep 05, 2014
Par Value 0.001
Shareholders
Shareholders of Record 515 a/o Sep 05, 2014
Short Selling Data
Short Interest 0 (-100%)
Sep 30, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security